Page last updated: 2024-10-31

metyrapone and Central Nervous System Diseases

metyrapone has been researched along with Central Nervous System Diseases in 6 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raubenheimer, PJ1
Young, EA1
Andrew, R1
Seckl, JR1
Rinne, UK1
RĂ¼edi, B1
Wertheimer, J1
Felber, JP1
Vannotti, A1
Hasui, K1
Krieger, DT2
Krieger, HP2

Trials

2 trials available for metyrapone and Central Nervous System Diseases

ArticleYear
The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Clinical endocrinology, 2006, Volume: 65, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Analysis of Variance; Area Under Curve; Central Nervous Sy

2006
Vasopressin test in central nervous system-pituitary disorders.
    Neuroendocrinology, 1968, Volume: 3, Issue:4

    Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma, Chromophobe; Adrenal Glands; Adrenocorticotropic Hor

1968

Other Studies

4 other studies available for metyrapone and Central Nervous System Diseases

ArticleYear
Disturbances of plasma cortisol circadian rhythm and of cortisol-ACTH feedback mechanism in central nervous system diseases.
    Rassegna di neurologia vegetativa, 1967, Aug-31, Volume: 21, Issue:3

    Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Central Nervous System Disease

1967
[Diurnal variation of plasma cortisol concentration in patients with various diseases and negative feedback mechanism of the pituitary-adrenal axis].
    Nihon Naibunpi Gakkai zasshi, 1969, Sep-20, Volume: 45, Issue:6

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Central Nervous Sys

1969
Effects of organic brain lesions on adrenal cortical activity.
    Research publications - Association for Research in Nervous and Mental Disease, 1966, Volume: 43

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Aldosterone; Brain Diseases; Brain Neoplasms; Central Ner

1966
Circadian variation of the plasma 17-hydroxycorticosteroids in central nervous system disease.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:9

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Brain Neoplasms; Central Nervous System Diseases; Circ

1966